Once-weekly GLP-1R agonists: moving the goal posts.
Lancet Diabetes Endocrinol · 2018
Last updated 2026-05-28| Journal | Lancet Diabetes Endocrinol, 2018 |
|---|---|
| Citations | 3 |
| Relative citation ratio | 0.13 |
| NIH percentile | 9 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, Chronic Kidney Disease, Mash |
Full record and abstract on PubMed 29397375 ↗